Hyperliquid Strategies Inc. is an entity formed from the proposed business combination between Sonnet Biotherapeutics and Rorschach. The combined company holds approximately 12.6 million HYPE tokens and a minimum of $305 million in cash at closing. Its stated operational structure is to manage a treasury that includes both digital and fiat assets.